Literature DB >> 23525834

The effect of part-time sick leave for employees with mental disorders.

Jan Høgelund1, Anders Holm, Lene Falgaard Eplov.   

Abstract

BACKGROUND: Part-time sick leave (PTSL) allows employees on full-time sick leave (FTSL) to resume work at reduced hours. When the partly absent employee's health improves, working hours are increased until the employee is able to work regular hours. Studies have found that PTSL is an effective instrument for reducing sick leave durations for employees with musculoskeletal disorders and for employees on sick leave in general. This is the first published article to document how PTSL affects sick leave durations for employees with mental disorders. AIM: The aim is to estimate the effect of PTSL on the duration until returning to regular working hours for employees with mental disorders. We compare this effect to that of PTSL for employees with non-mental disorders ('other disorders').
METHODS: We use combined survey and register data about 226 employees on long-term sick leave with mental disorders and 638 employees with other disorders. These data contain information about type of disorder, PTSL and FTSL (full-time sick leave) durations, and various background characteristics. We use a mixed proportional hazard regression model that allows us to control for unobserved differences between employees on PTSL and those on FTSL.
RESULTS: Our analyses show that PTSL has no effect on the duration until returning to regular working hours for employees with mental disorders. Furthermore, looking at specific disorders such as depression and stress-related conditions, we find no significant effects of PTSL. In contrast, in line with previous research, we find that PTSL significantly reduces the duration until returning to regular working hours for employees with other disorders. The analyses also illustrate the importance of controlling for unobserved differences between employees on PTSL and those on FTSL. Without this control, PTSL significantly reduces the duration until returning to regular working hours. When we control for unobserved characteristics, this effect decreases, and for employees with mental disorders the effect vanishes entirely. DISCUSSION AND LIMITATIONS: The lack of an effect of PTSL for employees with mental disorders needs replication in other studies. If subsequent studies confirm our findings, one should not necessarily conclude that PTSL is an ineffective intervention: PTSL may play a role in combination with other workplace interventions and in combination with person-centred interventions. The study is limited by self-reported data about disorders and a relatively small number of employees with mental disorders. CONCLUSION AND IMPLICATIONS: Our findings suggest that while PTSL reduces sick leave durations for employees with other disorders, it does not affect sick leave durations for employees with mental disorders. These results may indicate that PTSL by itself is insufficient for promoting the return to work of employees with mental disorders. FUTURE RESEARCH: Future studies could benefit from larger data sets with disorder information based on medical assessments. In addition to quantitative effect studies, future studies could focus on qualitative workplace mechanisms that may counteract the potential positive effects of PTSL for employees on sick leave with mental disorders.

Entities:  

Mesh:

Year:  2012        PMID: 23525834

Source DB:  PubMed          Journal:  J Ment Health Policy Econ        ISSN: 1099-176X


  9 in total

1.  Long-term sick leave and the impact of a graded return-to-work program: evidence from Germany.

Authors:  Udo Schneider; Roland Linder; Frank Verheyen
Journal:  Eur J Health Econ       Date:  2015-07-17

2.  Effectiveness of Graded Return to Work After Multimodal Rehabilitation in Patients with Mental Disorders: A Propensity Score Analysis.

Authors:  Marco Streibelt; Wolfgang Bürger; Karen Nieuwenhuijsen; Matthias Bethge
Journal:  J Occup Rehabil       Date:  2018-03

3.  Mental health economics: bridging research, practice and policy.

Authors:  Dominic Hodgkin; Massimo Moscarelli; Agnes Rupp; Samuel H Zuvekas
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

4.  Effectiveness of new legislation on partial sickness benefit on work participation: a quasi-experiment in Finland.

Authors:  Johanna Kausto; Eira Viikari-Juntura; Lauri J Virta; Raija Gould; Aki Koskinen; Svetlana Solovieva
Journal:  BMJ Open       Date:  2014-12-24       Impact factor: 2.692

Review 5.  Effectiveness of Integration and Re-Integration into Work Strategies for Persons with Chronic Conditions: A Systematic Review of European Strategies.

Authors:  Carla Sabariego; Michaela Coenen; Elizabeth Ito; Klemens Fheodoroff; Chiara Scaratti; Matilde Leonardi; Anastasia Vlachou; Panayiota Stavroussi; Valentina Brecelj; Dare S Kovačič; Eva Esteban
Journal:  Int J Environ Res Public Health       Date:  2018-03-19       Impact factor: 3.390

6.  Workplace flexibility important for part-time sick leave selection-an exploratory cross-sectional study of long-term sick listed in Norway.

Authors:  Martin Inge Standal; Odin Hjemdal; Lene Aasdahl; Vegard Stolsmo Foldal; Roar Johnsen; Egil Andreas Fors; Roger Hagen
Journal:  BMC Public Health       Date:  2021-04-15       Impact factor: 3.295

7.  Effectiveness of psychoeducation in reducing sickness absence and improving mental health in individuals at risk of having a mental disorder: a randomised controlled trial.

Authors:  Pernille Pedersen; Hans Jørgen Søgaard; Merete Labriola; Ellen A Nohr; Chris Jensen
Journal:  BMC Public Health       Date:  2015-08-08       Impact factor: 3.295

8.  The impact of self-reported health and register-based prescription medicine purchases on re-employment chances: A prospective study.

Authors:  Annemette Coop Svane-Petersen; Sofie Dencker-Larsen
Journal:  SSM Popul Health       Date:  2016-08-24

9.  Furthering the Evidence of the Effectiveness of Employment Strategies for People with Mental Disorders in Europe: A Systematic Review.

Authors:  Amalia Muñoz-Murillo; Eva Esteban; Carolina C Ávila; Klemens Fheodoroff; Josep Maria Haro; Matilde Leonardi; Beatriz Olaya
Journal:  Int J Environ Res Public Health       Date:  2018-04-24       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.